Paracetamol Injection 500mg/5mL

Paracetamol / Acetaminophen Injection
  • Dosage: Acetaminophen (Paracetamol) 500mg
  • Volume:  5 ml per  Ampoule
  • Packaging: 5 ml ampoule*5/tray*1 box*600/carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NameParacetamol Injection
Specification500mg/5mL (100mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientParacetamol (Acetaminophen)
Route of AdministrationIntravenous (infusion after dilution, or direct injection as applicable)
Packaging5mL amber glass ampoule or vial with rubber stopper and aluminum flip-off cap
StorageStore below 25°C, protected from light. Do not freeze. Keep container in outer carton until use.
Shelf Life24 months (unopened)

Product Overview

Paracetamol Injection 500mg/5mL is a sterile, aqueous solution of paracetamol (also known as acetaminophen) intended for intravenous administration. Each 5mL ampoule or vial contains 500mg of paracetamol, providing a concentration of 100mg/mL. This formulation is designed for use in clinical settings where oral administration is not feasible or when a rapid onset of action is desired.

Paracetamol Injection 500mg/5mL: What the Published Guidance Says

The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.

Paracetamol Injection 500mg/5mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Analgesics & NSAIDs range overview.

These points are quoted because they shape how Paracetamol Injection 500mg/5mL is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Ordering Parameters for Paracetamol Injection 500mg/5mL

Product NameParacetamol Injection
Specification500mg/5mL (100mg/mL)
Dosage FormSterile Solution for Injection / Infusion
Active IngredientParacetamol (Acetaminophen)
Route of AdministrationIntravenous (infusion after dilution, or direct injection as applicable)
StorageStore below 25°C, protected from light. Do not freeze. Keep container in outer carton until use.
Therapeutic groupAnalgesics & NSAIDs — Analgesics & NSAIDs
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Piroxicam Injection 1ml:10mg, Lysine Acetylsalicylate Injection 7ml:900mg Ampoule, Diclofenac Sodium Injection 3mL:75mg, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Paracetamol Injection 500mg/5mL is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

  • Pack size: 5mL amber glass ampoule or vial with rubber stopper and aluminum flip-off cap. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep container in outer carton until use..
  • Shelf life: 24 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.

This page describes Paracetamol Injection 500mg/5mL as a product of the non-opioid analgesics and NSAIDs named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Paracetamol Injection 500mg/5mL: Common Procurement Questions

What pack size is available for Paracetamol Injection 500mg/5mL?

The reference pack is 5mL amber glass ampoule or vial with rubber stopper and aluminum flip-off cap. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of Paracetamol Injection 500mg/5mL?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months.

Does the batch documentation for Paracetamol Injection 500mg/5mL support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Can you supply sustained-release or combination analgesics?

Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.

Which strengths of paracetamol oral liquid should we order?

The WHO Model List notes that offering both 120 mg/5 mL and 125 mg/5 mL on one market causes prescribing and dispensing confusion. We recommend selecting one strength per market and will supply accordingly.

Products Commonly Ordered with Paracetamol Injection 500mg/5mL

Browse the full Analgesics & NSAIDs range; all Injectables; the complete product catalogue.

Request a Quotation for Paracetamol Injection 500mg/5mL

Send the specification, pack size, quantity and destination market for Paracetamol Injection 500mg/5mL 500mg/5mL and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products